Back-to-back studies unveil the design and ability to program a molecule that could eventually be harnessed to reduce cellular damage common in many diseases
CURRENT ISSUE - January/February 2026
Applying the Six Cs Helps Labs Deliver Results Stakeholders Can Rely On